Patents matching “The United States of America”

US 6194547

ETS2 repressor factor (ERF)

The United States of America, as represented by the Department of Health and Human Services · Granted Feb 27, 2001 · Expires Feb 22, 2021

US 6194390

Procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis

The United States of America, as represented by the Department of Health and Human Services · Granted Feb 27, 2001 · Expires Feb 22, 2021

US 6193949

Method of sire selection using naloxone challenge tests and kits thereof

The United States of America, as represented by the Secretary of Agriculture · Granted Feb 27, 2001 · Expires Feb 22, 2021

US 6193982

Anti-cyanovirin antibody with an internal image of gp120, a method of use thereof, and a method of using a cyanovirin to induce an immune response to gp120

The United States of America, as represented by the Department of Health and Human Services · Granted Feb 27, 2001 · Expires Feb 22, 2021

US 6194388

Immunomodulatory oligonucleotides

The United States of America · Granted Feb 27, 2001 · Expires Feb 22, 2021

US 6190656

Immunologic enhancement with intermittent interleukin-2 therapy

The United States of America, as represented by the Department of Health and Human Services · Granted Feb 20, 2001 · Expires Feb 15, 2021

US 6190859

Method and kit for detection of dengue virus

The United States of America as represented by the Secretary of the Army · Granted Feb 20, 2001 · Expires Feb 15, 2021

US 6187306

Melanoma cell lines expressing shared immunodominant melanoma antigens and methods of using same

The United States of America, as represented by the Department of Health and Human Services · Granted Feb 13, 2001 · Expires Feb 8, 2021

US 6187775

Acridone-derived compounds useful as antineoplastic and antiretroviral agents

The United States of America, as represented by the Department of Health and Human Services · Granted Feb 13, 2001 · Expires Feb 8, 2021

US 6187745

Method of preventing nephrotoxicity caused by cyclosporins and tacrolimus

The United States of America, as represented by the Department of Health and Human Services · Granted Feb 13, 2001 · Expires Feb 8, 2021

US 6184339

High strength polymeric networks derived from (meth) acrylate resins with organofluorine content and process for preparing same

The United States of America as represented by the Secretary of the Commerce · Granted Feb 6, 2001 · Expires Feb 1, 2021

US 6183752

Restenosis/atherosclerosis diagnosis, prophylaxis and therapy

The United States of America, as represented by the Department of Health and Human Services · Granted Feb 6, 2001 · Expires Feb 1, 2021

US 6184024

Chimeric and/or growth-restricted flaviviruses

The United States of America, as represented by the Department of Health and Human Services · Granted Feb 6, 2001 · Expires Feb 1, 2021

US 6184246

Inhibition of cytokine production by polymethoxylated flavones

The United States of America, as represented by the Secretary of Agriculture · Granted Feb 6, 2001 · Expires Feb 1, 2021

US 6180110

Attenuated hepatitis a virus vaccine which grows in MRC-5 cells

The United States of America, as represented by the Department of Health and Human Services · Granted Jan 30, 2001 · Expires Jan 25, 2021

US 6177534

Silylated resins and the synthesis thereof

Government of the United States of America, as represented by the Secretary of Commerce · Granted Jan 23, 2001 · Expires Jan 18, 2021

US 6177415

Bacteriohopanetetrol and related compounds useful for modulation of lipoxygenase activity and anti-inflammatory applications

The United States of America, as represented by the Secretary of Agriculture · Granted Jan 23, 2001 · Expires Jan 18, 2021

US 6174862

Neurotrophic peptides of activity dependent neurotrophic factor

The United States of America, as represented by the Department of Health and Human Services · Granted Jan 16, 2001 · Expires Jan 11, 2021

US 6174666

Method of eliminating inhibitory/instability regions from mRNA

The United States of America, as represented by the Department of Health and Human Services · Granted Jan 16, 2001 · Expires Jan 11, 2021

US 6171596

Oligomeric HIV-1 envelope glycoproteins

The United States of America, as represented by the Department of Health and Human Services · Granted Jan 9, 2001 · Expires Jan 4, 2021

US 6172070

Substituted O6-benzyl-8-aza-guanines and 6(4)-benzyloxypyrimidines

The United States of America, as represented by the Department of Health and Human Services · Granted Jan 9, 2001 · Expires Jan 4, 2021

US 6165460

Generation of immune responses to prostate-specific antigen (PSA)

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 26, 2000 · Expires Dec 21, 2020

US 6165781

Modified adeno-associated virus vector capable of expression from a novel promoter

The United States of America, as represented by the Department of Health and Human Services · Granted Dec 26, 2000 · Expires Dec 21, 2020

US 6162897

17q-linked breast and ovarian cancer susceptibility gene

The United States of America, as represented by the Department of Health and Human Services · Granted Dec 19, 2000 · Expires Dec 14, 2020